English
简体中文
Total: £ 56.28
Published Date: 2024-10-17 | Pages: 81 | Tables: 188 | Pharma & Healthcare
C5 inhibitors are a class of drugs that specifically target the protein C5 in the complement system. The complement system is part of the immune system and plays a vital role in immune defense and inflammation. C5 is one of the key components of the complement cascade.
The global market for C5 Complement Inhibitor was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for C5 Complement Inhibitor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of C5 Complement Inhibitor by region & country, by Type, and by Application.
The C5 Complement Inhibitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding C5 Complement Inhibitor.
Market Segmentation
By Company
Alexion
Segment by Type:
Eculizumab
Raflizumab
Segment by Application
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Atypical Hemolytic Uremic Syndrome (aHUS)
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of C5 Complement Inhibitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of C5 Complement Inhibitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of C5 Complement Inhibitor in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 C5 Complement Inhibitor Product Introduction
1.2 Global C5 Complement Inhibitor Market Size Forecast
1.2.1 Global C5 Complement Inhibitor Sales Value (2019-2030)
1.2.2 Global C5 Complement Inhibitor Sales Volume (2019-2030)
1.2.3 Global C5 Complement Inhibitor Sales Price (2019-2030)
1.3 C5 Complement Inhibitor Market Trends & Drivers
1.3.1 C5 Complement Inhibitor Industry Trends
1.3.2 C5 Complement Inhibitor Market Drivers & Opportunity
1.3.3 C5 Complement Inhibitor Market Challenges
1.3.4 C5 Complement Inhibitor Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global C5 Complement Inhibitor Players Revenue Ranking (2023)
2.2 Global C5 Complement Inhibitor Revenue by Company (2019-2024)
2.3 Global C5 Complement Inhibitor Players Sales Volume Ranking (2023)
2.4 Global C5 Complement Inhibitor Sales Volume by Company Players (2019-2024)
2.5 Global C5 Complement Inhibitor Average Price by Company (2019-2024)
2.6 Key Manufacturers C5 Complement Inhibitor Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers C5 Complement Inhibitor Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of C5 Complement Inhibitor
2.9 C5 Complement Inhibitor Market Competitive Analysis
2.9.1 C5 Complement Inhibitor Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by C5 Complement Inhibitor Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C5 Complement Inhibitor as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Eculizumab
3.1.2 Raflizumab
3.2 Global C5 Complement Inhibitor Sales Value by Type
3.2.1 Global C5 Complement Inhibitor Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global C5 Complement Inhibitor Sales Value, by Type (2019-2030)
3.2.3 Global C5 Complement Inhibitor Sales Value, by Type (%) (2019-2030)
3.3 Global C5 Complement Inhibitor Sales Volume by Type
3.3.1 Global C5 Complement Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global C5 Complement Inhibitor Sales Volume, by Type (2019-2030)
3.3.3 Global C5 Complement Inhibitor Sales Volume, by Type (%) (2019-2030)
3.4 Global C5 Complement Inhibitor Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Paroxysmal Nocturnal Hemoglobinuria (PNH)
4.1.2 Atypical Hemolytic Uremic Syndrome (aHUS)
4.1.3 Other
4.2 Global C5 Complement Inhibitor Sales Value by Application
4.2.1 Global C5 Complement Inhibitor Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global C5 Complement Inhibitor Sales Value, by Application (2019-2030)
4.2.3 Global C5 Complement Inhibitor Sales Value, by Application (%) (2019-2030)
4.3 Global C5 Complement Inhibitor Sales Volume by Application
4.3.1 Global C5 Complement Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global C5 Complement Inhibitor Sales Volume, by Application (2019-2030)
4.3.3 Global C5 Complement Inhibitor Sales Volume, by Application (%) (2019-2030)
4.4 Global C5 Complement Inhibitor Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global C5 Complement Inhibitor Sales Value by Region
5.1.1 Global C5 Complement Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global C5 Complement Inhibitor Sales Value by Region (2019-2024)
5.1.3 Global C5 Complement Inhibitor Sales Value by Region (2025-2030)
5.1.4 Global C5 Complement Inhibitor Sales Value by Region (%), (2019-2030)
5.2 Global C5 Complement Inhibitor Sales Volume by Region
5.2.1 Global C5 Complement Inhibitor Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global C5 Complement Inhibitor Sales Volume by Region (2019-2024)
5.2.3 Global C5 Complement Inhibitor Sales Volume by Region (2025-2030)
5.2.4 Global C5 Complement Inhibitor Sales Volume by Region (%), (2019-2030)
5.3 Global C5 Complement Inhibitor Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America C5 Complement Inhibitor Sales Value, 2019-2030
5.4.2 North America C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe C5 Complement Inhibitor Sales Value, 2019-2030
5.5.2 Europe C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific C5 Complement Inhibitor Sales Value, 2019-2030
5.6.2 Asia Pacific C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America C5 Complement Inhibitor Sales Value, 2019-2030
5.7.2 South America C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa C5 Complement Inhibitor Sales Value, 2019-2030
5.8.2 Middle East & Africa C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions C5 Complement Inhibitor Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions C5 Complement Inhibitor Sales Value
6.2.1 Key Countries/Regions C5 Complement Inhibitor Sales Value, 2019-2030
6.2.2 Key Countries/Regions C5 Complement Inhibitor Sales Volume, 2019-2030
6.3 United States
6.3.1 United States C5 Complement Inhibitor Sales Value, 2019-2030
6.3.2 United States C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.3.3 United States C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe C5 Complement Inhibitor Sales Value, 2019-2030
6.4.2 Europe C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China C5 Complement Inhibitor Sales Value, 2019-2030
6.5.2 China C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.5.3 China C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan C5 Complement Inhibitor Sales Value, 2019-2030
6.6.2 Japan C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea C5 Complement Inhibitor Sales Value, 2019-2030
6.7.2 South Korea C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia C5 Complement Inhibitor Sales Value, 2019-2030
6.8.2 Southeast Asia C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India C5 Complement Inhibitor Sales Value, 2019-2030
6.9.2 India C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
6.9.3 India C5 Complement Inhibitor Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alexion
7.1.1 Alexion Company Information
7.1.2 Alexion Introduction and Business Overview
7.1.3 Alexion C5 Complement Inhibitor Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Alexion C5 Complement Inhibitor Product Offerings
7.1.5 Alexion Recent Development
8 Industry Chain Analysis
8.1 C5 Complement Inhibitor Industrial Chain
8.2 C5 Complement Inhibitor Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 C5 Complement Inhibitor Sales Model
8.5.2 Sales Channel
8.5.3 C5 Complement Inhibitor Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. C5 Complement Inhibitor Market Trends
Table 2. C5 Complement Inhibitor Market Drivers & Opportunity
Table 3. C5 Complement Inhibitor Market Challenges
Table 4. C5 Complement Inhibitor Market Restraints
Table 5. Global C5 Complement Inhibitor Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global C5 Complement Inhibitor Revenue Market Share by Company (2019-2024)
Table 7. Global C5 Complement Inhibitor Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global C5 Complement Inhibitor Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market C5 Complement Inhibitor Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers C5 Complement Inhibitor Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers C5 Complement Inhibitor Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of C5 Complement Inhibitor
Table 13. Global C5 Complement Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in C5 Complement Inhibitor as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global C5 Complement Inhibitor Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global C5 Complement Inhibitor Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global C5 Complement Inhibitor Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global C5 Complement Inhibitor Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global C5 Complement Inhibitor Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global C5 Complement Inhibitor Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global C5 Complement Inhibitor Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global C5 Complement Inhibitor Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global C5 Complement Inhibitor Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global C5 Complement Inhibitor Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global C5 Complement Inhibitor Price by Type (2019-2024) & (US$/Unit)
Table 27. Global C5 Complement Inhibitor Price by Type (2025-2030) & (US$/Unit)
Table 28. Global C5 Complement Inhibitor Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global C5 Complement Inhibitor Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global C5 Complement Inhibitor Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global C5 Complement Inhibitor Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global C5 Complement Inhibitor Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global C5 Complement Inhibitor Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global C5 Complement Inhibitor Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global C5 Complement Inhibitor Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global C5 Complement Inhibitor Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global C5 Complement Inhibitor Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global C5 Complement Inhibitor Price by Application (2019-2024) & (US$/Unit)
Table 39. Global C5 Complement Inhibitor Price by Application (2025-2030) & (US$/Unit)
Table 40. Global C5 Complement Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global C5 Complement Inhibitor Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global C5 Complement Inhibitor Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global C5 Complement Inhibitor Sales Value by Region (2019-2024) & (%)
Table 44. Global C5 Complement Inhibitor Sales Value by Region (2025-2030) & (%)
Table 45. Global C5 Complement Inhibitor Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global C5 Complement Inhibitor Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global C5 Complement Inhibitor Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global C5 Complement Inhibitor Sales Volume by Region (2019-2024) & (%)
Table 49. Global C5 Complement Inhibitor Sales Volume by Region (2025-2030) & (%)
Table 50. Global C5 Complement Inhibitor Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global C5 Complement Inhibitor Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions C5 Complement Inhibitor Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions C5 Complement Inhibitor Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions C5 Complement Inhibitor Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions C5 Complement Inhibitor Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions C5 Complement Inhibitor Sales Volume, (2025-2030) & (K Units)
Table 57. Alexion Company Information
Table 58. Alexion Introduction and Business Overview
Table 59. Alexion C5 Complement Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Alexion C5 Complement Inhibitor Product Offerings
Table 61. Alexion Recent Development
Table 62. Key Raw Materials Lists
Table 63. Raw Materials Key Suppliers Lists
Table 64. C5 Complement Inhibitor Downstream Customers
Table 65. C5 Complement Inhibitor Distributors List
Table 66. Research Programs/Design for This Report
Table 67. Key Data Information from Secondary Sources
Table 68. Key Data Information from Primary Sources
List of Figures
Figure 1. C5 Complement Inhibitor Product Picture
Figure 2. Global C5 Complement Inhibitor Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global C5 Complement Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 4. Global C5 Complement Inhibitor Sales Volume (2019-2030) & (K Units)
Figure 5. Global C5 Complement Inhibitor Sales Price (2019-2030) & (US$/Unit)
Figure 6. C5 Complement Inhibitor Report Years Considered
Figure 7. Global C5 Complement Inhibitor Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global C5 Complement Inhibitor Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by C5 Complement Inhibitor Revenue in 2023
Figure 10. C5 Complement Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Eculizumab Picture
Figure 12. Raflizumab Picture
Figure 13. Global C5 Complement Inhibitor Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global C5 Complement Inhibitor Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global C5 Complement Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 16. Global C5 Complement Inhibitor Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global C5 Complement Inhibitor Price by Type (2019-2030) & (US$/Unit)
Figure 18. Product Picture of Paroxysmal Nocturnal Hemoglobinuria (PNH)
Figure 19. Product Picture of Atypical Hemolytic Uremic Syndrome (aHUS)
Figure 20. Product Picture of Other
Figure 21. Global C5 Complement Inhibitor Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global C5 Complement Inhibitor Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global C5 Complement Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global C5 Complement Inhibitor Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global C5 Complement Inhibitor Price by Application (2019-2030) & (US$/Unit)
Figure 26. North America C5 Complement Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 27. North America C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe C5 Complement Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific C5 Complement Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 32. South America C5 Complement Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 33. South America C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa C5 Complement Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa C5 Complement Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions C5 Complement Inhibitor Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions C5 Complement Inhibitor Sales Volume (%), (2019-2030)
Figure 38. United States C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 40. United States C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 44. China C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 45. China C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 46. China C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 56. India C5 Complement Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 57. India C5 Complement Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 58. India C5 Complement Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 59. C5 Complement Inhibitor Industrial Chain
Figure 60. C5 Complement Inhibitor Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
